HLA-C and neoplasm: The immune response to the combination treatment was characterized by (i) an increase in MHC and tumor-associated antigen expression on the tumor cell surface facilitating tumor cells lysis by CTL, (ii) a decrease in Treg in the tumor microenvironment, and (iii) an improved activity and expansion of adoptively transferred T cells [94,95] (Table 6).